Effect of Alpha-1 Antitrypsin Supplementation on Alcohol-Associated Hepatitis

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

July 31, 2025

Study Completion Date

December 31, 2026

Conditions

Alcohol-Associated Hepatitis

Interventions

DRUG

Alfa1 Antitrypsin

Participants will be treated intravenously with A1AT 120 mg/kg bodyweight once a week for 4 weeks (4 total infusions).

Trial Locations (1)

Medical University Innsbruck, Innsbruck

All Listed Sponsors

lead

Medical University Innsbruck

OTHER